Ravulizumab

ATC L04AJ02 · 10 markets · 24 records

Ravulizumab 10 markets · 24 records Forms

AU 5 records · 4 strengths

  • 1,100 mg/11 mLinjectionUltomiris also in GB·ES·FR
  • 300 mg/3 mLinjectionUltomiris also in GB·ES·FR
  • 100 mg/mLinjectionULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial also in SG unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Ultomiris 100mg/ml ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 3 records · 3 strengths

GB 3 records · 3 strengths

CA 2 records · 1 strengths

ES 2 records · 2 strengths

TW 2 records · 1 strengths

HK 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1100MG/11ML ×4

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    FR 2 records · 2 strengths

    SG 1 records · 1 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.